Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.
the authors show that targeting both glutamine degradation and mTOR inhibition effectively kills PI3K-altered cancer cells in pre-clinical and clinical settings for T-cell acute lymphoblastic ...
Pediatric patients with ALL were found to experience deficits in their motor skills between at least 1 month and 4 years after completing treatment.
“On Thursday, we started Total Body Irradiation for a 15-year-old girl,” he said. The patient has relapsed B-Cell Acute Lymphoblastic Leukemia and will undergo Haploidentical BMT with her ...
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...